How many insider trades does FilingIQ track for TCRT?

FilingIQ tracks 30 Form 4 insider transactions for TCRT (Alaunos Therapeutics, Inc.), covering filings from Jun 22, 2022 onwards. 3 of those were filed in the last 90 days.

Are TCRT insiders net buyers or net sellers?

Across the full Form 4 history for TCRT, 2 transactions (7%) were open-market purchases and 3 (10%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does TCRT insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is TCRT in?

Alaunos Therapeutics, Inc. (TCRT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $6.72M.

TCRT insider trading

NasdaqCM Healthcare

Alaunos Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

7% / 10%

Market cap

$6.72M

About Alaunos Therapeutics, Inc.

Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops small molecules to treat obesity and other metabolic disorders. The company develops an oral obesity compound that addresses shortcomings of injectable GLP-1 receptor agonists, including preserving lean muscle mass. It also evaluates ALN1001 and related derivatives on lipid deposition and gene expression. In addition, the company develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is headquartered in Houston, Texas.

Company website: www.alaunos.com

TCRT insider activity at a glance

FilingIQ has scored 30 insider transactions for TCRT since Jun 22, 2022. The most recent filing in our index is dated Apr 29, 2026.

Across the full history, 2 open-market purchases and 3 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on TCRT insider trades is 63.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live TCRT trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for TCRT?: FilingIQ tracks 30 Form 4 insider transactions for TCRT (Alaunos Therapeutics, Inc.), covering filings from Jun 22, 2022 onwards. 3 of those were filed in the last 90 days.
Are TCRT insiders net buyers or net sellers?: Across the full Form 4 history for TCRT, 2 transactions (7%) were open-market purchases and 3 (10%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does TCRT insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is TCRT in?: Alaunos Therapeutics, Inc. (TCRT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $6.72M.

Methodology & sources

Every TCRT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.